• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于传感聚合物的用于轻松直观检测唾液中新冠病毒的芯片实验室。

Lab-on-a-chip for the easy and visual detection of SARS-CoV-2 in saliva based on sensory polymers.

作者信息

Arnaiz Ana, Guirado-Moreno José Carlos, Guembe-García Marta, Barros Rocio, Tamayo-Ramos Juan Antonio, Fernández-Pampín Natalia, García José M, Vallejos Saúl

机构信息

Departamento de Química, Facultad de Ciencias, Universidad de Burgos, Plaza de Misael Bañuelos s/n, 09001 Burgos, Spain.

Universidad Politécnica de Madrid, Calle Ramiro de Maeztu, 7, 28040 Madrid, Spain.

出版信息

Sens Actuators B Chem. 2023 Mar 15;379:133165. doi: 10.1016/j.snb.2022.133165. Epub 2022 Dec 15.

DOI:10.1016/j.snb.2022.133165
PMID:36536612
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9751010/
Abstract

The initial stages of the pandemic caused by SARS-CoV-2 showed that early detection of the virus in a simple way is the best tool until the development of vaccines. Many different tests are invasive or need the patient to cough up or even drag a sample of mucus from the throat area. Besides, the manufacturing time has proven insufficient in pandemic conditions since they were out of stock in many countries. Here we show a new method of manufacturing virus sensors and a proof of concept with SARS-CoV-2. We found that a fluorogenic peptide substrate of the main protease of the virus (Mpro) can be covalently immobilized in a polymer, with which a cellulose-based material can be coated. These sensory labels fluoresce with a single saliva sample of a positive COVID-19 patient. The results matched with that of the antigen tests in 22 of 26 studied cases (85% success rate).

摘要

由严重急性呼吸综合征冠状病毒2(SARS-CoV-2)引发的大流行初期表明,在疫苗研发出来之前,以简单方式早期检测该病毒是最佳手段。许多不同的检测方法具有侵入性,或者需要患者咳出甚至从咽喉部位取出一份黏液样本。此外,在大流行情况下,已证明这些检测方法的生产时间不足,因为在许多国家它们都缺货。在此,我们展示了一种制造病毒传感器的新方法以及针对SARS-CoV-2的概念验证。我们发现,该病毒主要蛋白酶(Mpro)的一种荧光肽底物可以共价固定在一种聚合物中,基于这种聚合物可以对一种纤维素基材料进行涂层处理。这些传感标记物在一名新冠病毒检测呈阳性患者的单一唾液样本中会发出荧光。在26个研究案例中的22个案例中,结果与抗原检测结果相符(成功率为85%)。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/47ff/9751010/9b8a3420e83c/gr4_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/47ff/9751010/fa1aaa48e5f4/ga1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/47ff/9751010/d4fec099d18a/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/47ff/9751010/6e1e9b650798/gr2_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/47ff/9751010/ec9fe036cea2/gr3_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/47ff/9751010/9b8a3420e83c/gr4_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/47ff/9751010/fa1aaa48e5f4/ga1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/47ff/9751010/d4fec099d18a/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/47ff/9751010/6e1e9b650798/gr2_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/47ff/9751010/ec9fe036cea2/gr3_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/47ff/9751010/9b8a3420e83c/gr4_lrg.jpg

相似文献

1
Lab-on-a-chip for the easy and visual detection of SARS-CoV-2 in saliva based on sensory polymers.基于传感聚合物的用于轻松直观检测唾液中新冠病毒的芯片实验室。
Sens Actuators B Chem. 2023 Mar 15;379:133165. doi: 10.1016/j.snb.2022.133165. Epub 2022 Dec 15.
2
Effectiveness and cost-effectiveness of four different strategies for SARS-CoV-2 surveillance in the general population (CoV-Surv Study): a structured summary of a study protocol for a cluster-randomised, two-factorial controlled trial.在普通人群中进行 SARS-CoV-2 监测的四种不同策略的有效性和成本效益(CoV-Surv 研究):一项关于集群随机、双因素对照试验的研究方案的结构化总结。
Trials. 2021 Jan 8;22(1):39. doi: 10.1186/s13063-020-04982-z.
3
Diagnostic Performance of Self-Collected Saliva Versus Nasopharyngeal Swab for the Molecular Detection of SARS-CoV-2 in the Clinical Setting.临床环境中,自我采集唾液与鼻咽拭子用于 SARS-CoV-2 分子检测的诊断性能比较。
Microbiol Spectr. 2021 Dec 22;9(3):e0046821. doi: 10.1128/Spectrum.00468-21. Epub 2021 Nov 3.
4
SARS-CoV-2 Cysteine-like Protease Antibodies Can Be Detected in Serum and Saliva of COVID-19-Seropositive Individuals.SARS-CoV-2 半胱氨酸蛋白酶抗体可在 COVID-19 血清阳性个体的血清和唾液中检测到。
J Immunol. 2020 Dec 1;205(11):3130-3140. doi: 10.4049/jimmunol.2000842. Epub 2020 Nov 4.
5
Discovery of a "Cocktail" of Potential SARS-COV-2 Main Protease Inhibitors through Virtual Screening of Known Chemical Components of Vitex negundo L. ("Lagundi").通过对牡荆(“Lagundi”)已知化学成分的虚拟筛选发现潜在 SARS-COV-2 主蛋白酶抑制剂“鸡尾酒”。
Med Chem. 2022;18(3):364-381. doi: 10.2174/1573406417666210618132003.
6
A lab-on-a-chip for the concurrent electrochemical detection of SARS-CoV-2 RNA and anti-SARS-CoV-2 antibodies in saliva and plasma.一种用于在唾液和血浆中同时电化学检测 SARS-CoV-2 RNA 和抗 SARS-CoV-2 抗体的芯片实验室。
Nat Biomed Eng. 2022 Aug;6(8):968-978. doi: 10.1038/s41551-022-00919-w. Epub 2022 Aug 8.
7
Saliva as a sample type for SARS-CoV-2 detection: implementation successes and opportunities around the globe.唾液样本用于 SARS-CoV-2 检测:全球实施成功及机遇。
Expert Rev Mol Diagn. 2022 May;22(5):519-535. doi: 10.1080/14737159.2022.2094250. Epub 2022 Jul 4.
8
Some Flavolignans as Potent Sars-Cov-2 Inhibitors Molecular Docking, Molecular Dynamic Simulations and ADME Analysis.一些类黄酮作为有效的 SARS-CoV-2 抑制剂:分子对接、分子动力学模拟和 ADME 分析。
Curr Comput Aided Drug Des. 2022;18(5):337-346. doi: 10.2174/1573409918666220816113516.
9
Identification of polyphenols from as SARS CoV-2 main protease inhibitors using docking and molecular dynamics simulation approaches.基于对接和分子动力学模拟方法鉴定 中的多酚类化合物作为 SARS CoV-2 主蛋白酶抑制剂。
J Biomol Struct Dyn. 2021 Oct;39(17):6747-6760. doi: 10.1080/07391102.2020.1802347. Epub 2020 Aug 7.
10
The British variant of the new coronavirus-19 (Sars-Cov-2) should not create a vaccine problem.新冠病毒-19(Sars-Cov-2)的英国变体不应造成疫苗问题。
J Biol Regul Homeost Agents. 2021 Jan-Feb;35(1):1-4. doi: 10.23812/21-3-E.

引用本文的文献

1
Sensory Polymers: Trends, Challenges, and Prospects Ahead.传感聚合物:当前的趋势、挑战与前景
Sensors (Basel). 2024 Jun 14;24(12):3852. doi: 10.3390/s24123852.

本文引用的文献

1
The SARS-CoV-2 main protease (M): Structure, function, and emerging therapies for COVID-19.严重急性呼吸综合征冠状病毒2型主要蛋白酶(M):结构、功能及针对2019冠状病毒病的新兴疗法
MedComm (2020). 2022 Jul 14;3(3):e151. doi: 10.1002/mco2.151. eCollection 2022 Sep.
2
The role of polymeric chains as a protective environment for improving the stability and efficiency of fluorogenic peptide substrates.聚合物链作为保护环境的作用,可提高荧光肽底物的稳定性和效率。
Sci Rep. 2022 May 25;12(1):8818. doi: 10.1038/s41598-022-12848-4.
3
Emerging COVID-19 variants and their impact on SARS-CoV-2 diagnosis, therapeutics and vaccines.
新型 COVID-19 变种及其对 SARS-CoV-2 诊断、治疗和疫苗的影响。
Ann Med. 2022 Dec;54(1):524-540. doi: 10.1080/07853890.2022.2031274.
4
A tale of two antiviral targets - and the COVID-19 drugs that bind them.两个抗病毒靶点的故事——以及与之结合的新冠病毒药物。
Nat Rev Drug Discov. 2022 Jan;21(1):3-5. doi: 10.1038/d41573-021-00202-8.
5
Glycan-Based Flow-Through Device for the Detection of SARS-COV-2.基于聚糖的 SARS-COV-2 检测流通式装置。
ACS Sens. 2021 Oct 22;6(10):3696-3705. doi: 10.1021/acssensors.1c01470. Epub 2021 Oct 11.
6
Molecular detections of coronavirus: current and emerging methodologies.冠状病毒的分子检测:当前和新兴的方法学。
Expert Rev Anti Infect Ther. 2022 Feb;20(2):199-210. doi: 10.1080/14787210.2021.1949986. Epub 2021 Jul 21.
7
Diagnostic accuracy and feasibility of patient self-testing with a SARS-CoV-2 antigen-detecting rapid test.患者用 SARS-CoV-2 抗原检测快速检测试剂盒自测的诊断准确性和可行性。
J Clin Virol. 2021 Aug;141:104874. doi: 10.1016/j.jcv.2021.104874. Epub 2021 May 29.
8
Sensitive Detection of SARS-CoV-2 Using a SERS-Based Aptasensor.基于 SERS 的适体传感器灵敏检测 SARS-CoV-2。
ACS Sens. 2021 Jun 25;6(6):2378-2385. doi: 10.1021/acssensors.1c00596. Epub 2021 May 21.
9
A global panel database of pandemic policies (Oxford COVID-19 Government Response Tracker).一个全球性的大流行病政策面板数据库(牛津 COVID-19 政府应对追踪器)。
Nat Hum Behav. 2021 Apr;5(4):529-538. doi: 10.1038/s41562-021-01079-8. Epub 2021 Mar 8.
10
Detection of SARS-CoV-2 by CRISPR/Cas12a-Enhanced Colorimetry.通过 CRISPR/Cas12a 增强比色法检测 SARS-CoV-2。
ACS Sens. 2021 Mar 26;6(3):1086-1093. doi: 10.1021/acssensors.0c02365. Epub 2021 Mar 8.